Case Report

Nicotine Replacement Therapy-associated Syndrome of Inappropriate Antidiuretic Hormone

Authors: Christopher K. Finch, PHARMD, Miranda R. Andrus, PHARMD, William A. Curry, MD

Abstract

Nicotine has been documented to regulate the release of plasma arginine vasopressin (AVP). The literature is inconclusive about the effects of nicotine replacement therapy on AVP release, although cigarette smoking has been shown to increase the release of AVP. No clinical case reports have documented the possible association between nicotine replacement and hyponatremia through AVP release. We report a case of a 39-year-old man who experienced syndrome of inappropriate antidiuretic hormone while on nicotine patch therapy. We theorize that the constant serum concentration of nicotine levels provided through the patch may cause hyponatremia through the continuous stimulation of vasopressin.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Pomerleau OF. Nicotine and the central nervous system: Biobehavioral effects of cigarette smoking. Am J Med 1992; 93( 1A): 2S–7S.
 
2. Burn JH, Truelove LH, Burn I. The antidiuretic action of nicotine and of smoking. Br Med J 1945: 1: 403–406.
 
3. Feldberg W, Guertzenstein PG, Rocha e Silva M Jr. Vasopressin release by nicotine: The site of action. Br J Pharmacol 1975; 54: 463–474.
 
4. Lewis AAG, Chalmers TM. Nicotine test for the investigation of diabetes insipidus. Clin Sci 1951; 10: 137–144.
 
5. Fuxe K, Andersson K, Eneroth P, et al. Neuroendocrine actions of nicotine and of exposure to cigarette smoke: Medical implications. Psychoneuroendocrinology 1989; 14: 19–41.
 
6. Goldsmith SR, Katz A, Crooks PA. Response of plasma arginine vasopressin to nicotine in normal man. Clin Pharmacol Ther 1988; 44: 478–481.
 
7. Hunsballe JM, Rittig S, Pedersen EB, et al. Smokeless nicotinergic stimulation of vasopressin secretion in patients with persisting nocturnal enuresis and controls. Scand J Urol Nephrol 2001; 35: 117–121.
 
8. Netscher DT, Wigoda P, Thornby J, et al. The hemodynamic and hematologic effects of cigarette smoking versus a nicotine patch. Plast Reconstr Surg 1995; 96: 681–688.
 
9. Baumann G, Lopez-Amor E, Dingman JF. Plasma arginine vasopressin in the syndrome of inappropriate antidiuretic hormone secretion. Am J Med 1972; 52: 19–24.
 
10. Rowe JW, Kilgore A, Robertson GL. Evidence in man that cigarette smoking induces vasopressin release via an airway-specific mechanism. J Clin Endocrinol Metab 1980; 51: 170–172.
 
11. Chiodera P, Volpi R, Capretti L, et al. Abnormal effect of cigarette smoking on pituitary hormone secretions in insulin-dependent diabetes mellitus. Clin Endocrinol (Oxf) 1997; 46: 351–357.
 
12. Shutty MS Jr. Cigarette use, drinking and voiding in schizophrenic patients with polydipsia and hyponatremia. Schizophr Res 1996; 21: 195–197.
 
13. Vieweg WV, David JJ, Rowe WT, et al. Correlation of cigarette-induced increase in serum nicotine levels with arginine vasopressin concentrations in the syndrome of self-induced water intoxication and psychosis (SIWIP). Can J Psychiatry 1986; 31: 108–111.
 
14. Dalessio DJ. Nicotine and the antidiuretic hormone. JAMA 1969; 207: 954(letter).
 
15. Dixon BS, Anderson RJ. Pneumonia and the syndrome of inappropriate antidiuretic hormone secretion: Don’t pour water on the fire. Am Rev Respir Dis 1988; 138: 512–513(editorial).
 
16. Hill AR, Uribarri J, Mann J, et al. Altered water metabolism in tuberculosis: Role of vasopressin. Am J Med 1990; 88: 357–364.
 
17. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–245.
 
18. Robertson GL. Disorders of the neurohypophysis, in Braunwald E, Fauci AS, Kasper DL, et al (eds): Harrison’s Principles of Internal Medicine. New York, McGraw-Hill, 2001, ed 15, pp 2052–2060.
 
19. Jackson EK. Vasopressin and other agents affecting the renal conservation of water, in Hardman JG, Limbird LE, Gilman AG (eds): Goodman & Gilman’s The Pharmacological Basis of Therapeutics. New York, McGraw-Hill, 2001, ed 10, pp 789–809.